|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||0.00 - 0.00|
|Beta (5Y monthly)||0.17|
|PE ratio (TTM)||33.31|
|Earnings date||09 Nov 2023|
|Forward dividend & yield||2.35 (2.15%)|
|Ex-dividend date||10 Aug 2023|
|1y target est||130.11|
Astrazeneca (AZN) concluded the recent trading session at $66.62, signifying a +0.54% move from its prior day's close.
Shares of Conduit Pharmaceuticals (NASDAQ: CDT) were up more than 17% on Wednesday as of 11:30 a.m., after jumping up as much as 81% in the first hour of trading, leading to a brief halt in trading. Conduit calls itself a "disease agnostic life science company." With no major news announced, Wednesday's brief meteoric rise was nearly as surprising as the big fall a day before.
AstraZeneca (AZN) agrees to pay $425 million to settle lawsuits related to heartburn drugs, Nexium and Prilosec.